Literature DB >> 10615959

The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes.

J A Noble1, A M Valdes, G Thomson, H A Erlich.   

Abstract

HLA-DPB1 genotypes were determined for samples from 269 multiplex Caucasian families from the Human Biological Data Interchange. DRB1 and DQB1 loci were also characterized, allowing assignment of DPB1 alleles to haplotypes and calculation of linkage disequilibrium values. Frequencies for several DPB1 alleles differed significantly between patients and affected family-based control subjects. Some differences were attributable to linkage disequilibrium with DR and DQ alleles, whereas others were not. DPB1*0301 and DPB1*0202 alleles are predisposing for type 1 diabetes in these data, not only in analyses of individual alleles, but also in genotype analyses. DPB1*0402 appears protective; however, stratification analysis indicates that its protective effect is specific for DR3 haplotypes. A protective role for DPB1*0401 is suggested by genotype analysis. For increased statistical power, DPB1 alleles were pooled into three categories: susceptible, neutral, and protective after removal of effects due to linkage disequilibrium with DR-DQ. Analysis of these pools suggests that DPB1 primarily affects susceptibility to, rather than protection from, type 1 diabetes in a dominant fashion. This effect is more apparent in patients with genotypes other than the highest risk DR3/DR4-DQB1*0302 genotype. These data support a role for the DPB1 locus in conferring susceptibility to type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10615959     DOI: 10.2337/diabetes.49.1.121

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

1.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.

Authors:  N J Cox; B Wapelhorst; V A Morrison; L Johnson; L Pinchuk; R S Spielman; J A Todd; P Concannon
Journal:  Am J Hum Genet       Date:  2001-08-15       Impact factor: 11.025

2.  Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.

Authors:  Erin E Baschal; Suparna A Sarkar; Theresa A Boyle; Janet C Siebert; Jean M Jasinski; Katharine R Grabek; Taylor K Armstrong; Sunanda R Babu; Pamela R Fain; Andrea K Steck; Marian J Rewers; George S Eisenbarth
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

Review 3.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

Review 4.  Genetics of type 1 diabetes.

Authors:  Janelle A Noble; Henry A Erlich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

5.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

6.  The HLA class I A locus affects susceptibility to type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes; Teodorica L Bugawan; Raymond J Apple; Glenys Thomson; Henry A Erlich
Journal:  Hum Immunol       Date:  2002-08       Impact factor: 2.850

7.  Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1.

Authors:  A M Valdes; G Thomson
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

8.  Association analysis of SNPs in the IL4R locus with type I diabetes.

Authors:  H A Erlich; K Lohman; S J Mack; A M Valdes; C Julier; D Mirel; J A Noble; G E Morahan; S S Rich
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

9.  Evidence for association of the TCF7 locus with type I diabetes.

Authors:  H A Erlich; A M Valdes; C Julier; D Mirel; J A Noble
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 10.  A functional framework for interpretation of genetic associations in T1D.

Authors:  Gerald T Nepom; Jane H Buckner
Journal:  Curr Opin Immunol       Date:  2012-07-26       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.